The Pituitary Society Inc

Nonprofit profile at a glance

EIN
223307141
IRS 990 coverage
2013–2024
Forms available
Form 990 2024
Location
Los Angeles, CA, USA
Phone
3109889486
Rating
61
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Heart and Circulatory System Diseases, Disorders

Reported finances

Revenue
$753,709
Expenses
$483,415
Assets
$3,079,505
Liabilities
$689,239

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

13 people listed

Executive titles in this filing

  • RICHARD ROSS MBBS MD FRCP (PRESIDENT)

People named in this filing

  • RICHARD ROSS MBBS MD FRCP (PRESIDENT)
  • SHLOMO MELMED MB CHB MACP FRCP (SECRETARY-TREASURER)
  • KEN HO MD (CO-DIRECTOR, PROGRAMS)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Our mission is to provide scientists, clinicians and trainees with the most up-to-date, reliable research and education on the biology of the pituitary gland and the causes, diagnosis and treatment of pituitary gland related diseases, in order to improve patient care and to provide a uniquely international forum for professional growth and scientific exchange.

What it reported doing in 2024

Preceptorship course for fellows-in-trainingthis course, held in january 2025, was the seventh since its inception. The course was attended by approximately 225 fellows-in-training. Fellows were required to submit an interesting pituitary case to attend the course. Cases were reviewed by faculty and four-to-six were selected to be presented by the fellows during the case discussion. Faculty recorded presentations on all pituitary pathology were viewed by the fellows prior to the live webinars to allow for more interactive learning.over the last decade, many endocrinology fellowship programs reduced the training requirements from 3 years to 2 years to be eligible for board certification. In parallel, diabetes and obesity incidence and prevalence increased significantly, limiting clinical experiences on other rarer, nevertheless severe and potentially lethal diseases, such as pituitary disorders. Therefore, this course taught by leading international experts, addressed some of these issues by reviewing for trainees advancements in diagnosis and treatment of hypopituitarism, growth hormone deficiency, cushing's syndrome and acromegaly as well as management of pituitary disease in the post-covid era.

Operating model

Revenue model
Donor-supported. 85% of the money available for current operations came from contributions and gifts.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - The filed numbers largely add up and most voting board members are independent. A relatively small share of available resources goes toward mission work and a relatively small share of total spending goes to programs.

Rating breakdown

  • Financial Efficiency: 22
  • Transparency & Controls: 92
  • Accountability: 88
  • Sustainability: 80
  • Growth: 60

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 23.3%; rating input score 23
  • Program expense ratio: 26.6%; rating input score 27
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
  • Governance controls: 5 of 7 controls in place; rating input score 71
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 35.9%; rating input score 87; 87th percentile among comparable filings
  • Total-asset coverage ratio: 6.37; rating input score 88; 88th percentile among comparable filings
  • Liabilities to assets ratio: 0.22; rating input score 30; 30th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 81; 81st percentile among comparable filings

Growth

  • Program expense growth: -9.4% per year; rating input score 0; 5th percentile among comparable filings
  • Revenue growth: 2.8% per year; rating input score 100; 29th percentile among comparable filings
  • Asset growth: 12.8% per year; rating input score 100; 67th percentile among comparable filings

Details

  • Where the money goes: 23.3% of revenue deployed · 26.6% of spending went to programs
  • Governance: 13 of 13 board members independent · 5 of 7 filing controls reported
  • Programs: 3 filed program accomplishments · $129K in reported program spending
  • Leadership: top reported pay $0 · 13 people listed
  • Consistency: 22 of 22 current checks pass
  • Schedules: 4 filed schedules · includes major donors
  • Filing history: 12 filing years from 2013 to 2024
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Financial Efficiency: Mission deployment rate scored 23/100.
  • High — Financial Efficiency: Program expense ratio scored 27/100.
  • High — Growth: Program expense growth scored 0/100.
  • Review — Accountability: Governance controls: Independent financial-statement audit not reported.
  • Moderate — Sustainability: Liabilities to assets ratio scored 30/100.